Transforming growth factor-beta expression in mouse lung carcinogenesis (Q41026603)

25 September 2017

title

Transforming growth factor-beta expression in mouse lung carcinogenesis (English)

1 reference

25 September 2017

1 reference

Jakowlew SB

1

1 reference

25 September 2017

Moody TW

series ordinal

2

1 reference

25 September 2017

You L

series ordinal

3

1 reference

25 September 2017

Mariano JM

series ordinal

4

1 reference

25 September 2017

publication date

1 July 1998

1 reference

Experimental Lung Research

25 September 2017

number of pages

15

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 September 2017

volume

24

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

579-593

1 reference

Multimodality therapy for stage IIIA (N2) lung cancer. An overview

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

cDNA cloning by PCR of rat transforming growth factor beta-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Cloning by polymerase chain reaction of a new mouse TGF-beta, mTGF-beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Transcripts for transforming growth factors in human breast cancer: clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Increased secretion of type beta transforming growth factor accompanies viral transformation of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

Pattern of growth factor, proto-oncogene and carcinoembryonic antigen gene expression in human colorectal carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/01902149809087387

10.3109/01902149809087387

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference